Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01710605
Recruitment Status : Unknown
Verified April 2018 by Institut Curie.
Recruitment status was:  Active, not recruiting
First Posted : October 19, 2012
Last Update Posted : April 9, 2018
Sponsor:
Information provided by (Responsible Party):
Institut Curie